XM does not provide services to residents of the United States of America.
B
B

Brenntag

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Brenntag Becomes Pharmaceutical Applications Distributor For K+S

BRIEF-Brenntag Becomes Pharmaceutical Applications Distributor For K+S Dec 2 (Reuters) - Brenntag SE BNRGn.DE : BECOMES GLOBAL STRATEGIC DISTRIBUTOR FOR K+S REGARDING THREE HIGH-PURITY SALTS FOR PHARMACEUTICAL APPLICATIONS Further company coverage: [BNRGn.DE] (Gdansk Newsroom)
B
K

JPM ups EU chemicals on valuation despite uncertain macro outlook

BUZZ-JPM ups EU chemicals on valuation despite uncertain macro outlook ** European chemicals are "still bobbing around the bottom", J.P. Morgan says in a sector note, cites earnings of the cyclical names remaining at or close to trough levels and cheap valuations ** It notes that earnings momentum will likely be negative in near-term due to uncerta
B
L
S
U
V
A
A
J
Y

Brenntag CEO Will Not Extend His Contract Beyond 2025

BRIEF-Brenntag CEO Will Not Extend His Contract Beyond 2025 Nov 26 (Reuters) - BRENNTAG SE BNRGn.DE : BRENNTAG CEO DR. CHRISTIAN KOHLPAINTNER WILL NOT EXTEND HIS CONTRACT BEYOND 2025 WILL IMMEDIATELY INITIATE AN ORDERLY PROCESS FOR CEO SUCCESSION Source text: ID:nEQ1TWxWNa Further company coverage: [BNRGn.DE] (Gdansk Newsroom)
B

STOXX 600 jumps over 1% to one-week high on real-estate boost

UPDATE 2-STOXX 600 jumps over 1% to one-week high on real-estate boost STOXX 600 up 1.2% EZ business activity declines abruptly in Nov -PMI Thales tanks on Anglo-French bribery investigation Games Workshop hits record high on upbeat HY forecast Updates to closing levels By Ankika Biswas, Joao Manuel Vicente Mauricio and Pranav Kashyap Nov 22 (Reuters) - European real estate stocks surged, propelling the benchmark index to a one-week high on Friday, while easing of geopolitical tensions also reli
B
N
N
S
U
E
F
U
G

Berenberg ups Brenntag on 'realistic' consensus, strategy shift

BUZZ-Berenberg ups Brenntag on 'realistic' consensus, strategy shift ** Berenberg raises Brenntag BNRGn.DE to "buy" from "hold", citing more realistic consensus numbers for 2025 and the company's shift in strategy away from pursuing a legal split of its Essentials and Specialties businesses ** Shares in the German chemicals distributor, which are down 30% YTD, rise around 3%, to the top of German blue-chip index .GDAXI ** "We think Brenntag's stock is now priced too pessimistically moving into F
B
G

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.